FDA Approves Larotrectinib for NTRK+ Cancers

This topic has 0 replies, 1 voice, and was last updated 5 years, 4 months ago by gavin.

Viewing 1 post (of 1 total)

Author

Posts
November 27, 2018 at 11:40 am #97831

gavin
Moderator

FDA Approves Larotrectinib for NTRK+ Cancers

https://www.onclive.com/web-exclusives/fda-approves-larotrectinib-for-ntrk-cancers?utm_medium=email&utm_campaign=ONC%20Breaking%20News%2011-26-18&utm_content=ONC%20Breaking%20News%2011-26-18+CID_d9414f686f7947ae0ba28a92e2ec5e74&utm_source=CM%20ONCLIVE&utm_term=READ%20MORE

Thanks to OncLive 2006-2018 Intellisphere, LLC for this piece.

Gavin
Author

Posts

Viewing 1 post (of 1 total)

The forum ‘Websites’ is closed to new topics and replies.

©2022 - All Rights Reserved, Cholangiocarcinoma Foundation